From October 16-19, 2018, the 28th National Congress on respiratory diseases was held in Moscow.
Staff from the scientific-research centre on cystic fibrosis (CF) played an active role in it. Anna S. Yefremova, research fellow from the stem cell laboratory, gave a presentation on modern approaches (used throughout the world and now in our country as well) to selecting targeted therapy for CF patients with rare mutations and an assessment of the treatment’s efficacy.
Поделиться в соцсетях